In conversation with Philip Broadley of AstraZeneca - Ep 52

The pandemic forced many organisations to adapt at pace and this was certainly the case for those at the heart of developing and producing a viable vaccine. Over the past 18 months the pioneering work of AstraZeneca has thrust them into the spotlight and they suddenly became front page news. What was it like to have the eyes of the world on you, while maintaining the controls and transparency needed to retain trust? In this episode, Philip Broadley, Senior Independent Non-Executive Director and Audit Committee Chair of AstraZeneca, joins PwC’s Head of Audit, Hemione Hudson, and host Teresa Owusu-Adjei. They discuss how disruption led to innovation in the face of a global crisis. And looking towards the global challenge of combating climate change, what lessons can be learned about responding to a crisis at speed?